title: Challenges in studying very rare cancer outcomes and infrequent exposures: example of teriparatide and osteosarcoma.
authors.affiliation: RTI Health Solutions, RTI International, Research Triangle Park, NC. Electronic address: eandrews@rti.org.
authors.forename: Elizabeth B
authors.initials: EB
authors.lastname: Andrews
authors.affiliation: RTI Health Solutions, RTI International, Research Triangle Park, NC.
authors.forename: Alicia
authors.initials: A
authors.lastname: Gilsenan
authors.affiliation: RTI Health Solutions, RTI International, Research Triangle Park, NC.
authors.forename: Kirk
authors.initials: K
authors.lastname: Midkiff
authors.affiliation: RTI Health Solutions, RTI International, Research Triangle Park, NC.
authors.forename: David
authors.initials: D
authors.lastname: Harris
mesh_terms: D001859:Bone Neoplasms / Q000139:chemically induced; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy; D012516:Osteosarcoma / Q000139:chemically induced*; D017063:Outcome Assessment, Health Care; D010281:Parathyroid Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D019379:Teriparatide / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D010281:Parathyroid Hormone; D019379:Teriparatide